22 results
The extinct marine megafauna of the Phanerozoic
- Catalina Pimiento, Kristína Kocáková, Gregor H. Mathes, Thodoris Argyriou, Edwin-Alberto Cadena, Jack A. Cooper, Dirley Cortés, Daniel J. Field, Christian Klug, Torsten M. Scheyer, Ana M. Valenzuela-Toro, Timon Buess, Meike Günter, Amanda M. Gardiner, Pascale Hatt, Geraldine Holdener, Giulia Jacober, Sabrina Kobelt, Sheldon Masseraz, Ian Mehli, Sarah Reiff, Eva Rigendinger, Mimo Ruckstuhl, Santana Schneider, Clarissa Seige, Nathalie Senn, Valeria Staccoli, Jessica Baumann, Livio Flüeler, Lino J. Guevara, Esin Ickin, Kimberley C. Kissling, Janis Rogenmoser, Dominik Spitznagel, Jaime A. Villafaña, Chiara Zanatta
-
- Journal:
- Cambridge Prisms: Extinction / Volume 2 / 2024
- Published online by Cambridge University Press:
- 17 May 2024, e7
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
The modern marine megafauna is known to play important ecological roles and includes many charismatic species that have drawn the attention of both the scientific community and the public. However, the extinct marine megafauna has never been assessed as a whole, nor has it been defined in deep time. Here, we review the literature to define and list the species that constitute the extinct marine megafauna, and to explore biological and ecological patterns throughout the Phanerozoic. We propose a size cut-off of 1 m of length to define the extinct marine megafauna. Based on this definition, we list 706 taxa belonging to eight main groups. We found that the extinct marine megafauna was conspicuous over the Phanerozoic and ubiquitous across all geological eras and periods, with the Mesozoic, especially the Cretaceous, having the greatest number of taxa. Marine reptiles include the largest size recorded (21 m; Shonisaurus sikanniensis) and contain the highest number of extinct marine megafaunal taxa. This contrasts with today’s assemblage, where marine animals achieve sizes of >30 m. The extinct marine megafaunal taxa were found to be well-represented in the Paleobiology Database, but not better sampled than their smaller counterparts. Among the extinct marine megafauna, there appears to be an overall increase in body size through time. Most extinct megafaunal taxa were inferred to be macropredators preferentially living in coastal environments. Across the Phanerozoic, megafaunal species had similar extinction risks as smaller species, in stark contrast to modern oceans where the large species are most affected by human perturbations. Our work represents a first step towards a better understanding of the marine megafauna that lived in the geological past. However, more work is required to expand our list of taxa and their traits so that we can obtain a more complete picture of their ecology and evolution.
The effect of vitamin D supplementation on pain: an analysis of data from the D-Health randomised controlled trial
- Aninda Rahman, Mary Waterhouse, Catherine Baxter, Briony Duarte Romero, Donald S. A. McLeod, Bruce K. Armstrong, Peter R. Ebeling, Dallas R. English, Gunter Hartel, Michael G. Kimlin, Rachel O’Connell, Jolieke C. van der Pols, Alison J. Venn, Penelope M. Webb, David C. Whiteman, Rachel E. Neale
-
- Journal:
- British Journal of Nutrition / Volume 130 / Issue 4 / 28 August 2023
- Published online by Cambridge University Press:
- 25 November 2022, pp. 633-640
- Print publication:
- 28 August 2023
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
Observational studies suggest that 25-hydroxy vitamin D (25(OH)D) concentration is inversely associated with pain. However, findings from intervention trials are inconsistent. We assessed the effect of vitamin D supplementation on pain using data from a large, double-blind, population-based, placebo-controlled trial (the D-Health Trial). 21 315 participants (aged 60–84 years) were randomly assigned to a monthly dose of 60 000 IU vitamin D3 or matching placebo. Pain was measured using the six-item Pain Impact Questionnaire (PIQ-6), administered 1, 2 and 5 years after enrolment. We used regression models (linear for continuous PIQ-6 score and log-binomial for binary categorisations of the score, namely ‘some or more pain impact’ and ‘presence of any bodily pain’) to estimate the effect of vitamin D on pain. We included 20 423 participants who completed ≥1 PIQ-6. In blood samples collected from 3943 randomly selected participants (∼800 per year), the mean (sd) 25(OH)D concentrations were 77 (sd 25) and 115 (sd 30) nmol/l in the placebo and vitamin D groups, respectively. Most (76 %) participants were predicted to have 25(OH)D concentration >50 nmol/l at baseline. The mean PIQ-6 was similar in all surveys (∼50·4). The adjusted mean difference in PIQ-6 score (vitamin D cf placebo) was 0·02 (95 % CI (−0·20, 0·25)). The proportion of participants with some or more pain impact and with the presence of bodily pain was also similar between groups (both prevalence ratios 1·01, 95 % CI (0·99, 1·03)). In conclusion, supplementation with 60 000 IU of vitamin D3/month had negligible effect on bodily pain.
What makes the psychosis ‘clinical high risk’ state risky: psychosis itself or the co-presence of a non-psychotic disorder?
- Laila Hasmi, Lotta-Katrin Pries, Margreet ten Have, Ron de Graaf, Saskia van Dorsselaer, Maarten Bak, Gunter Kenis, Alexander Richards, Bochao D. Lin, Michael C. O'Donovan, Jurjen J. Luykx, Bart P.F. Rutten, Sinan Guloksuz, Jim van Os
-
- Journal:
- Epidemiology and Psychiatric Sciences / Volume 30 / 2021
- Published online by Cambridge University Press:
- 06 July 2021, e53
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
Aims
Although attenuated psychotic symptoms in the psychosis clinical high-risk state (CHR-P) almost always occur in the context of a non-psychotic disorder (NPD), NPD is considered an undesired ‘comorbidity’ epiphenomenon rather than an integral part of CHR-P itself. Prospective work, however, indicates that much more of the clinical psychosis incidence is attributable to prior mood and drug use disorders than to psychosis clinical high-risk states per se. In order to examine this conundrum, we analysed to what degree the ‘risk’ in CHR-P is indexed by co-present NPD rather than attenuated psychosis per se.
MethodsWe examined the incidence of early psychotic experiences (PE) with and without NPD (mood disorders, anxiety disorders, alcohol/drug use disorders), in a prospective general population cohort (n = 6123 at risk of incident PE at baseline). Four interview waves were conducted between 2007 and 2018 (NEMESIS-2). The incidence of PE, alone (PE-only) or with NPD (PE + NPD) was calculated, as were differential associations with schizophrenia polygenic risk score (PRS-Sz), environmental, demographical, clinical and cognitive factors.
ResultsThe incidence of PE + NPD (0.37%) was lower than the incidence of PE-only (1.04%), representing around a third of the total yearly incidence of PE. Incident PE + NPD was, in comparison with PE-only, differentially characterised by poor functioning, environmental risks, PRS-Sz, positive family history, prescription of antipsychotic medication and (mental) health service use.
ConclusionsThe risk in ‘clinical high risk’ states is mediated not by attenuated psychosis per se but specifically the combination of attenuated psychosis and NPD. CHR-P/APS research should be reconceptualised from a focus on attenuated psychotic symptoms with exclusion of non-psychotic DSM-disorders, as the ‘pure' representation of a supposedly homotypic psychosis risk state, towards a focus on poor-outcome NPDs, characterised by a degree of psychosis admixture, on the pathway to psychotic disorder outcomes.
Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
- Gamze Erzin, Lotta-Katrin Pries, Jim van Os, Laura Fusar-Poli, Philippe Delespaul, Gunter Kenis, Jurjen J. Luykx, Bochao D. Lin, Alexander L. Richards, Berna Akdede, Tolga Binbay, Vesile Altınyazar, Berna Yalınçetin, Güvem Gümüş-Akay, Burçin Cihan, Haldun Soygür, Halis Ulaş, Eylem Şahin Cankurtaran, Semra Ulusoy Kaymak, Marina M. Mihaljevic, Sanja Andric-Petrovic, Tijana Mirjanic, Miguel Bernardo, Gisela Mezquida, Silvia Amoretti, Julio Bobes, Pilar A. Saiz, Maria Paz García-Portilla, Julio Sanjuan, Eduardo J. Aguilar, Jose Luis Santos, Estela Jiménez-López, Manuel Arrojo, Angel Carracedo, Gonzalo López, Javier González-Peñas, Mara Parellada, Nadja P. Maric, Cem Atbaşoğlu, Alp Ucok, Köksal Alptekin, Meram Can Saka, Genetic Risk and Outcome of Psychosis (GROUP) investigators, Celso Arango, Micheal C. O’Donovan, Bart P. F. Rutten, Sinan Guloksuz
-
- Journal:
- European Psychiatry / Volume 64 / Issue 1 / 2021
- Published online by Cambridge University Press:
- 19 March 2021, e25
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
Background
A cumulative environmental exposure score for schizophrenia (exposome score for schizophrenia [ES-SCZ]) may provide potential utility for risk stratification and outcome prediction. Here, we investigated whether ES-SCZ was associated with functioning in patients with schizophrenia spectrum disorder, unaffected siblings, and healthy controls.
MethodsThis cross-sectional sample consisted of 1,261 patients, 1,282 unaffected siblings, and 1,525 healthy controls. The Global Assessment of Functioning (GAF) scale was used to assess functioning. ES-SCZ was calculated based on our previously validated method. The association between ES-SCZ and the GAF dimensions (symptom and disability) was analyzed by applying regression models in each group (patients, siblings, and controls). Additional models included polygenic risk score for schizophrenia (PRS-SCZ) as a covariate.
ResultsES-SCZ was associated with the GAF dimensions in patients (symptom: B = −1.53, p-value = 0.001; disability: B = −1.44, p-value = 0.001), siblings (symptom: B = −3.07, p-value < 0.001; disability: B = −2.52, p-value < 0.001), and healthy controls (symptom: B = −1.50, p-value < 0.001; disability: B = −1.31, p-value < 0.001). The results remained the same after adjusting for PRS-SCZ. The degree of associations of ES-SCZ with both symptom and disability dimensions were higher in unaffected siblings than in patients and controls. By analyzing an independent dataset (the Genetic Risk and Outcome of Psychosis study), we replicated the results observed in the patient group.
ConclusionsOur findings suggest that ES-SCZ shows promise for enhancing risk prediction and stratification in research practice. From a clinical perspective, ES-SCZ may aid in efforts of clinical characterization, operationalizing transdiagnostic clinical staging models, and personalizing clinical management.
A replication study of JTC bias, genetic liability for psychosis and delusional ideation
- Cécile Henquet, Jim van Os, Lotta K. Pries, Christian Rauschenberg, Philippe Delespaul, Gunter Kenis, Jurjen J. Luykx, Bochao D. Lin, Alexander L. Richards, Berna Akdede, Tolga Binbay, Vesile Altınyazar, Berna Yalınçetin, Güvem Gümüş-Akay, Burçin Cihan, Haldun Soygür, Halis Ulaş, Eylem S. Cankurtaran, Semra U. Kaymak, Marina M. Mihaljevic, Sanja S. Petrovic, Tijana Mirjanic, Miguel Bernardo, Gisela Mezquida, Silvia Amoretti, Julio Bobes, Pilar A. Saiz, Maria P. García-Portilla, Julio Sanjuan, Eduardo J. Aguilar, Jose L. Santos, Estela Jiménez-López, Manuel Arrojo, Angel Carracedo, Gonzalo López, Javier González-Peñas, Mara Parellada, Nadja P. Maric, Cem Atbaşoğlu, Alp Ucok, Köksal Alptekin, Meram C. Saka, Celso Arango, Michael O'Donovan, Bart P.F. Rutten, Sinan Gülöksüz
-
- Journal:
- Psychological Medicine / Volume 52 / Issue 9 / July 2022
- Published online by Cambridge University Press:
- 13 October 2020, pp. 1777-1783
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
Background
This study attempted to replicate whether a bias in probabilistic reasoning, or ‘jumping to conclusions’(JTC) bias is associated with being a sibling of a patient with schizophrenia spectrum disorder; and if so, whether this association is contingent on subthreshold delusional ideation.
MethodsData were derived from the EUGEI project, a 25-centre, 15-country effort to study psychosis spectrum disorder. The current analyses included 1261 patients with schizophrenia spectrum disorder, 1282 siblings of patients and 1525 healthy comparison subjects, recruited in Spain (five centres), Turkey (three centres) and Serbia (one centre). The beads task was used to assess JTC bias. Lifetime experience of delusional ideation and hallucinatory experiences was assessed using the Community Assessment of Psychic Experiences. General cognitive abilities were taken into account in the analyses.
ResultsJTC bias was positively associated not only with patient status but also with sibling status [adjusted relative risk (aRR) ratio : 4.23 CI 95% 3.46–5.17 for siblings and aRR: 5.07 CI 95% 4.13–6.23 for patients]. The association between JTC bias and sibling status was stronger in those with higher levels of delusional ideation (aRR interaction in siblings: 3.77 CI 95% 1.67–8.51, and in patients: 2.15 CI 95% 0.94–4.92). The association between JTC bias and sibling status was not stronger in those with higher levels of hallucinatory experiences.
ConclusionsThese findings replicate earlier findings that JTC bias is associated with familial liability for psychosis and that this is contingent on the degree of delusional ideation but not hallucinations.
Should inflammatory bowel disease be a contraindication to radiation therapy: a systematic review of acute and late toxicities
- J. Nathan Cantrell, Gabriel S. Vidal, Hussein Bitar, Salahuddin Ahmad, Tyler C. Gunter
-
- Journal:
- Journal of Radiotherapy in Practice / Volume 20 / Issue 4 / December 2021
- Published online by Cambridge University Press:
- 22 September 2020, pp. 480-489
-
- Article
- Export citation
-
Background:
Inflammatory bowel disease (IBD) [i.e., Crohn’s disease (CD) and ulcerative colitis (UC)] has been considered a relative contraindication for radiation therapy (RT) to the abdomen or pelvis, potentially preventing patients with a diagnosis of IBD from receiving definitive therapy for their malignancy.
Method:Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) conventions, a PubMed/MEDLINE literature search was conducted using the keywords RT, brachytherapy, inflammatory bowel disease, Crohn’s disease, ulcerative colitis and toxicity.
Results:A total of 1,206 publications were screened with an addition of 8 studies identified through hand searching. Nineteen studies met the inclusion criteria for quantitative analysis. The total population across all studies was 497 patients, 50·5% having UC, 37% having CD and an additional 12·5% having unspecified IBD. Primary gastrointestinal malignancy (55%) followed by prostate cancer (40%) composed the bulk of the population. Acute and late grade 3 or greater gastrointestinal specific toxicity ranged from 0–23% to 0–13% respectively for those patients with IBD treated with RT to the abdomen or pelvis. In the literature reviewed, RT does not appear to increase fistula or stricture formation or IBD flares; however, one study did note RT to be a statistically significant risk factor for subsequent IBD flare on multivariate analysis.
Conclusions:A review of reported acute and late toxicities suggests that patients with IBD should still be considered for definitive radiotherapy. Patient characteristics including IBD distribution relative to the irradiated field, inflammatory activity at the time of radiation, overall disease severity and disease phenotype in the case of CD (fistulising versus stricturing versus inflammatory only) should be considered on an individual basis when evaluating potential patients. When possible, advanced techniques with strict organ at risk dose constraints should be employed to limit toxicity in this patient population.
Tetragonal Almandine-Pyrope Phase, TAPP: finally a name for it, the new mineral jeffbenite
- Fabrizio Nestola, Antony D. Burnham, Luca Peruzzo, Leonardo Tauro, Matteo Alvaro, Michael J. Walter, Mickey Gunter, Chiara Anzolini, Simon C. Kohn
-
- Journal:
- Mineralogical Magazine / Volume 80 / Issue 7 / December 2016
- Published online by Cambridge University Press:
- 02 January 2018, pp. 1219-1232
-
- Article
- Export citation
-
Jeffbenite, ideally Mg3Al2Si3O8, previously known as tetragonal-almandine-pyrope-phase ('TAPP’), has been characterized as a new mineral from an inclusion in an alluvial diamond from São Luiz river, Juina district of Mato Grosso, Brazil. Its density is 3.576 g/cm3 and its microhardness is ∼7. Jeffbenite is uniaxial (-) with refractive indexes ω = 1.733(5) and ε = 1.721 (5). The crystals are in general transparent emerald green.
Its approximate chemical formula is (Mg262Fe2+0.27)(Al186Cr016)(Si2 g2Al018)O12 with very minor amounts of Mn, Na and Ca. Laser ablation ICP-MS showed that jeffbenite has a very low concentration of trace elements. Jeffbenite is tetragonal with space group I42d, cell edges being a = 6.5231(1) and c = 18.1756(3) Å. The main diffraction lines of the powder diagram are [d (in Å), intensity, hkl]: 2.647, 100, 2 0 4; 1.625, 44, 3 2 5; 2.881, 24, 2 1 1; 2.220, 19, 2 0 6; 1.390, 13, 4 2 4; 3.069, 11,2 0 2; 2.056, 11,2 2 4; 1.372, 11,2 0 12.
The structural formula of jeffbenite can be written as (M1)(M2)2(M3)2(T1)(T2)2O12 with M1 dominated by Mg, M2 dominated by Al, M3 dominated again by Mg and both T1 and T2 almost fully occupied by Si. The two tetrahedra do not share any oxygen with each other (i.e. jeffbenite is classified as an orthosilicate).
Jeffbenite was approved as a new mineral by the IMA Commission on New Minerals and Mineral Names with the code IMA 2014-097. Its name is after Jeffrey W. Harris and Ben Harte, two world-leading scientists in diamond research. The petrological importance of jeffbenite is related to its very deep origin, which may allow its use as a pressure marker for detecting super-deep diamonds. Previous experimental work carried out on a Ti-rich jeffbenite establishes that it can be formed at 13 GPa and 1700 K as maximum P-T conditions.
Absorption, Translocation, and Metabolism of 14C-Halosulfuron in Grafted Eggplant and Tomato
- Sushila Chaudhari, Katherine M. Jennings, David W. Monks, David L. Jordan, Christopher C. Gunter, Frank J. Louws
-
- Journal:
- Weed Technology / Volume 31 / Issue 6 / December 2017
- Published online by Cambridge University Press:
- 27 September 2017, pp. 908-914
-
- Article
- Export citation
-
Grafted plants are a combination of two different interspecific or intraspecific scion and rootstock. Determination of herbicidal selectivity of the grafted plant is critical given their increased use in vegetable production. Differential absorption, translocation, and metabolism play an important role in herbicide selectivity of plant species because these processes affect the herbicide amount delivered to the site of action. Therefore, experiments were conducted to determine absorption, translocation, and metabolism of halosulfuron in grafted and non-grafted tomato and eggplant. Transplant type included non-grafted tomato cultivar Amelia, non-grafted eggplant cultivar Santana, Amelia scion grafted onto Maxifort tomato rootstock (A-Maxifort) and Santana scion grafted onto Maxifort rootstock (S-Maxifort). Plants were treated POST with commercially formulated halosulfuron at 39 g ai ha-1 followed by 14C-halosulfuron under controlled laboratory conditions. Amount of 14C-halosufuron was quantified in leaf wash, treated leaf, scion shoot, rootstock shoot, and root at 6, 12, 24, 48, and 96 h after treatment (HAT) using liquid scintillation spectrometry. No differences were observed between transplant types with regard to absorption and translocation of 14C-halosulfuron. Absorption of 14C-halosulfuron increased with time, reaching 10 and 74% of applied at 6 and 96 HAT, respectively. Translocation of 14C-halosulfuron was limited to the treated leaf, which reached maximum (66% of applied) at 96 HAT, whereas minimal (<4% of applied) translocation occurred in scion shoot, rootstock shoot, and root. Tomato plants metabolized halosulfuron faster compared to eggplant regardless of grafting. Of the total amount of 14C-halosulfuron absorbed into the plant, 9 to 14% remained in the form of the parent compound in tomato compared with 25 to 26% in eggplant at 48 HAT. These results indicate that grafting did not affect absorption, translocation, and metabolism of POST halosulfuron in tomato and eggplant.
Response of Drought-Stressed Grafted and Nongrafted Tomato to Postemergence Metribuzin
- Sushila Chaudhari, Katherine M. Jennings, David W. Monks, David L. Jordan, Christopher C. Gunter, Frank J. Louws
-
- Journal:
- Weed Technology / Volume 31 / Issue 3 / June 2017
- Published online by Cambridge University Press:
- 31 May 2017, pp. 447-454
-
- Article
- Export citation
-
Tomato grafting is practiced worldwide as an innovative approach to manage stress from drought, waterlogging, insects, and diseases. Metribuzin is a commonly used herbicide in tomato but has potential to cause injury after application if plants are under stress. The influence of metribuzin on grafted tomato under drought-stress has not been studied. Greenhouse experiments were conducted in Raleigh, NC to determine the tolerance of drought-stressed grafted and non-grafted tomato to metribuzin. The tomato cultivar ‘Amelia’ was used as the scion in grafted tomato, and for the non-grafted control. Two hybrid tomato ‘Beaufort’ and ‘Maxifort’ were used as rootstocks for grafted plants. Drought-stress treatments included: no drought-stress; 3 d of drought-stress before metribuzin application with no drought-stress after application (3 d DSB); and 3 d of drought-stress before metribuzin application with 3 d of drought-stress after application (3 d DSBA). Metribuzin was applied at 550 g ai ha−1. No difference in injury from metribuzin was observed in grafted and non-grafted plants. However, at 7 and 14 d after metribuzin treatment (DMT), less injury was observed on tomato in the 3 d DSBA treatment (5 and 2% injury, respectively) than on plants in the 3 d DSB treatment (15 and 8% injury, respectively) or those that were never drought-stressed (18 and 11% injury, respectively). Photosynthesis and stomatal conductance measured prior to metribuzin application were reduced similarly in grafted and non-grafted tomato subjected to drought-stress. Photosynthesis and stomatal conductance of grafted and non-grafted tomato at 7 DMT was not different among drought-stress treatments or metribuzin treatments. Grafted and non-grafted tomato plants under drought-stress exhibit similar tolerance to metribuzin. The risk of metribuzin injury to grafted tomato under drought-stress is similar to non-grafted tomato.
Response of Eggplant (Solanum melongena) Grafted onto Tomato (Solanum lycopersicum) Rootstock to Herbicides
- Sushila Chaudhari, Katherine M. Jennings, David W. Monks, David L. Jordan, Christopher C. Gunter, Nicholas T. Basinger, Frank J. Louws
-
- Journal:
- Weed Technology / Volume 30 / Issue 1 / March 2016
- Published online by Cambridge University Press:
- 20 January 2017, pp. 207-216
-
- Article
- Export citation
-
Tomato rootstocks have been successfully used for eggplant production. However, the safety of herbicides registered in tomato has not been tested on grafted eggplant, which is a combination of tomato rootstock and eggplant scion. Greenhouse and field experiments were conducted to determine response of grafted eggplant on tomato rootstock to napropamide, metribuzin, halosulfuron, trifluralin, S-metolachlor, and fomesafen herbicides. In greenhouse experiments, herbicide treatments included pretransplant S-metolachlor (400 and 800 g ai ha−1), pre- or posttransplant metribuzin (140 and 280 g ai ha−1), and posttransplant halosulfuron (18 and 36 g ai ha−1). In field experiments, herbicide treatments included pretransplant fomesafen (280 and 420 g ai ha−1), halosulfuron (39 and 52 g ha−1), metribuzin (280 and 550 g ha−1), napropamide (1,120 and 2,240 g ai ha−1), S-metolachlor (800 and 1,060 g ha−1), and trifluralin (560 and 840 g ai ha−1). The eggplant cultivar ‘Santana' was used as the scion and nongrafted control, and two hybrid tomatoes ‘RST-04−106-T' and ‘Maxifort' were used as rootstocks for grafted plants. In both greenhouse and field experiments, there was no difference between grafted and nongrafted eggplant in terms of injury caused by herbicides. Metribuzin posttransplant at 140 and 280 g ha−1 caused 94 and 100% injury to grafted and nongrafted eggplant 4 wk after treatment. In field experiments, pretransplant fomesafen, napropamide, S-metolachlor, and trifluralin caused less than 10% injury and no yield reduction in grafted and nongrafted eggplant. However, metribuzin caused injury and yield reduction in both grafted and nongrafted eggplant. Metribuzin at 550 g ha−1 caused 60 and 81% plant stand loss in 2013 and 2014, respectively. Halosulfuron reduced yield 24% in both grafted and nongrafted eggplant compared to nontreated control in 2013 but did not reduce yield in 2014. The pretransplant S-metolachlor, napropamide, fomesafen, and trifluralin are safe to use on eggplant grafted onto tomato rootstock, and will be a valuable addition to the toolkit of eggplant growers.
Response of Grafted Tomato (Solanum lycopersicum) to Herbicides
- Sushila Chaudhari, Katherine M. Jennings, David W. Monks, David L. Jordan, Christopher C. Gunter, Frank J. Louws
-
- Journal:
- Weed Technology / Volume 29 / Issue 4 / December 2015
- Published online by Cambridge University Press:
- 20 January 2017, pp. 800-809
-
- Article
- Export citation
-
Tomato grafting has gained increased attention in the United States as an alternative to methyl bromide to control soilborne pests and diseases. Although several herbicides are registered in tomato production, a lack of information exists on the effect of herbicides on grafted tomato. Greenhouse and field experiments were conducted to determine herbicide tolerance of grafted tomato. In greenhouse experiments, halosulfuron (27, 54, and 108 g ai ha−1), metribuzin (280, 560, and 1,120 g ai ha−1), and S-metolachlor (1,070, 2,140, and 3,200 g ai ha−1) were applied posttransplant to nongrafted ‘Amelia' and Amelia scion grafted onto ‘Maxifort' or ‘RST-04-106-T' tomato rootstocks. Although herbicide injury was observed, no differences were observed in grafted and nongrafted tomato response including visible injury assessments, plant height, and fresh weight. Tomato injury at 3 wk after herbicide application increased from 3 to 12, 1 to 87, and 0 to 37% as rate of halosulfuron, metribuzin, and S-metolachlor increased, respectively. In field experiments under plasticulture, herbicides applied pretransplant included fomesafen (280 and 420 g ai ha−1), halosulfuron (39 and 54 g ha−1), metribuzin (280 and 560 g ha−1), napropamide (1,120 and 2,240 g ha−1), S-metolachlor (800 and 1,070 g ha−1), and trifluralin (560 and 840 g ai ha−1). Amelia was used as the scion and the nongrafted control. ‘Anchor-T', ‘Beaufort', or Maxifort tomato were used as rootstocks for grafted plants. Fomesafen, halosulfuron, napropamide, and trifluralin initially caused greater injury to grafted tomato than to nongrafted tomato regardless of rootstock (Anchor-T, Beaufort, or Maxifort). However, by 4 wk after treatment, all grafted and nongrafted plants had recovered from herbicide injury. A transplant type-by-herbicide interaction was not observed for yield, but grafted A-Maxifort tomato produced greater total and marketable yield than nongrafted Amelia tomato. Grafted tomato exhibited similar tolerance as nongrafted tomato for all herbicides applied post- and pretransplant.
Critical Period for Weed Control in Grafted and Nongrafted Fresh Market Tomato
- Sushila Chaudhari, Katherine M. Jennings, David W. Monks, David L. Jordan, Christopher C. Gunter, Samuel J. McGowen, Frank J. Louws
-
- Journal:
- Weed Science / Volume 64 / Issue 3 / September 2016
- Published online by Cambridge University Press:
- 20 January 2017, pp. 523-530
-
- Article
- Export citation
-
Field experiments were conducted to determine the critical period for weed control (CPWC) in nongrafted ‘Amelia’ and Amelia grafted onto ‘Maxifort’ tomato rootstock grown in plasticulture. The establishment treatments (EST) consisted of two seedlings each of common purslane, large crabgrass, and yellow nutsedge transplanted at 1, 2, 3, 4, 5, 6, and 12 wk after tomato transplanting (WAT) and remained until tomato harvest to simulate weeds emerging at different times. The removal treatments (REM) consisted of the same weeds transplanted on the day of tomato transplanting and removed at 2, 3, 4, 5, 6, 8, and 12 WAT to simulate weeds controlled at different times. The beginning and end of the CPWC, based on a 5% yield loss of marketable tomato, was determined by fitting log-logistic and Gompertz models to the relative yield data representing REM and EST, respectively. In both grafted and nongrafted tomato, plant aboveground dry biomass increased as establishment of weeds was delayed and tomato plant biomass decreased when removal of weeds was delayed. For a given time of weed removal and establishment, grafted tomato plants produced higher biomass than nongrafted. The delay in establishment and removal of weeds resulted in weed biomass decrease and increase of the same magnitude, respectively, regardless of transplant type. The predicted CPWC was from 2.2 to 4.5 WAT in grafted tomato and from 3.3 to 5.8 WAT in nongrafted tomato. The length (2.3 or 2.5 wk) of the CPWC in fresh market tomato was not affected by grafting; however, the CPWC management began and ended 1 wk earlier in grafted tomato than in nongrafted tomato.
A Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure
- Sara Y. Tartof, Gunter K. Rieg, Rong Wei, Hung Fu Tseng, Steven J. Jacobsen, Kalvin C. Yu
-
- Journal:
- Infection Control & Hospital Epidemiology / Volume 36 / Issue 12 / December 2015
- Published online by Cambridge University Press:
- 21 September 2015, pp. 1409-1416
- Print publication:
- December 2015
-
- Article
- Export citation
-
BACKGROUND
Limitations in sample size, overly inclusive antibiotic classes, lack of adjustment of key risk variables, and inadequate assessment of cases contribute to widely ranging estimates of risk factors for Clostridium difficile infection (CDI).
OBJECTIVETo incorporate all key CDI risk factors in addition to 27 antibiotic classes into a single comprehensive model.
DESIGNRetrospective cohort study.
SETTINGKaiser Permanente Southern California.
PATIENTSMembers of Kaiser Permanente Southern California at least 18 years old admitted to any of its 14 hospitals from January 1, 2011, through December 31, 2012.
METHODSHospital-acquired CDI cases were identified by polymerase chain reaction assay. Exposure to major outpatient antibiotics (10 classes) and those administered during inpatient stays (27 classes) was assessed. Age, sex, self-identified race/ethnicity, Charlson Comorbidity Score, previous hospitalization, transfer from a skilled nursing facility, number of different antibiotic classes, statin use, and proton pump inhibitor use were also assessed. Poisson regression estimated adjusted risk of CDI.
RESULTSA total of 401,234 patients with 2,638 cases of incident CDI (0.7%) were detected. The final model demonstrated highest CDI risk associated with increasing age, exposure to multiple antibiotic classes, and skilled nursing facility transfer. Factors conferring the most reduced CDI risk were inpatient exposure to tetracyclines and first-generation cephalosporins, and outpatient macrolides.
CONCLUSIONSAlthough type and aggregate antibiotic exposure are important, the factors that increase the likelihood of environmental spore acquisition should not be underestimated. Operationally, our findings have implications for antibiotic stewardship efforts and can inform empirical and culture-driven treatment approaches.
Infect. Control Hosp. Epidemiol. 2015;36(12):1409–1416
Contributors
-
- By Mitchell Aboulafia, Frederick Adams, Marilyn McCord Adams, Robert M. Adams, Laird Addis, James W. Allard, David Allison, William P. Alston, Karl Ameriks, C. Anthony Anderson, David Leech Anderson, Lanier Anderson, Roger Ariew, David Armstrong, Denis G. Arnold, E. J. Ashworth, Margaret Atherton, Robin Attfield, Bruce Aune, Edward Wilson Averill, Jody Azzouni, Kent Bach, Andrew Bailey, Lynne Rudder Baker, Thomas R. Baldwin, Jon Barwise, George Bealer, William Bechtel, Lawrence C. Becker, Mark A. Bedau, Ernst Behler, José A. Benardete, Ermanno Bencivenga, Jan Berg, Michael Bergmann, Robert L. Bernasconi, Sven Bernecker, Bernard Berofsky, Rod Bertolet, Charles J. Beyer, Christian Beyer, Joseph Bien, Joseph Bien, Peg Birmingham, Ivan Boh, James Bohman, Daniel Bonevac, Laurence BonJour, William J. Bouwsma, Raymond D. Bradley, Myles Brand, Richard B. Brandt, Michael E. Bratman, Stephen E. Braude, Daniel Breazeale, Angela Breitenbach, Jason Bridges, David O. Brink, Gordon G. Brittan, Justin Broackes, Dan W. Brock, Aaron Bronfman, Jeffrey E. Brower, Bartosz Brozek, Anthony Brueckner, Jeffrey Bub, Lara Buchak, Otavio Bueno, Ann E. Bumpus, Robert W. Burch, John Burgess, Arthur W. Burks, Panayot Butchvarov, Robert E. Butts, Marina Bykova, Patrick Byrne, David Carr, Noël Carroll, Edward S. Casey, Victor Caston, Victor Caston, Albert Casullo, Robert L. Causey, Alan K. L. Chan, Ruth Chang, Deen K. Chatterjee, Andrew Chignell, Roderick M. Chisholm, Kelly J. Clark, E. J. Coffman, Robin Collins, Brian P. Copenhaver, John Corcoran, John Cottingham, Roger Crisp, Frederick J. Crosson, Antonio S. Cua, Phillip D. Cummins, Martin Curd, Adam Cureton, Andrew Cutrofello, Stephen Darwall, Paul Sheldon Davies, Wayne A. Davis, Timothy Joseph Day, Claudio de Almeida, Mario De Caro, Mario De Caro, John Deigh, C. F. Delaney, Daniel C. Dennett, Michael R. DePaul, Michael Detlefsen, Daniel Trent Devereux, Philip E. Devine, John M. Dillon, Martin C. Dillon, Robert DiSalle, Mary Domski, Alan Donagan, Paul Draper, Fred Dretske, Mircea Dumitru, Wilhelm Dupré, Gerald Dworkin, John Earman, Ellery Eells, Catherine Z. Elgin, Berent Enç, Ronald P. Endicott, Edward Erwin, John Etchemendy, C. Stephen Evans, Susan L. Feagin, Solomon Feferman, Richard Feldman, Arthur Fine, Maurice A. Finocchiaro, William FitzPatrick, Richard E. Flathman, Gvozden Flego, Richard Foley, Graeme Forbes, Rainer Forst, Malcolm R. Forster, Daniel Fouke, Patrick Francken, Samuel Freeman, Elizabeth Fricker, Miranda Fricker, Michael Friedman, Michael Fuerstein, Richard A. Fumerton, Alan Gabbey, Pieranna Garavaso, Daniel Garber, Jorge L. A. Garcia, Robert K. Garcia, Don Garrett, Philip Gasper, Gerald Gaus, Berys Gaut, Bernard Gert, Roger F. Gibson, Cody Gilmore, Carl Ginet, Alan H. Goldman, Alvin I. Goldman, Alfonso Gömez-Lobo, Lenn E. Goodman, Robert M. Gordon, Stefan Gosepath, Jorge J. E. Gracia, Daniel W. Graham, George A. Graham, Peter J. Graham, Richard E. Grandy, I. Grattan-Guinness, John Greco, Philip T. Grier, Nicholas Griffin, Nicholas Griffin, David A. Griffiths, Paul J. Griffiths, Stephen R. Grimm, Charles L. Griswold, Charles B. Guignon, Pete A. Y. Gunter, Dimitri Gutas, Gary Gutting, Paul Guyer, Kwame Gyekye, Oscar A. Haac, Raul Hakli, Raul Hakli, Michael Hallett, Edward C. Halper, Jean Hampton, R. James Hankinson, K. R. Hanley, Russell Hardin, Robert M. Harnish, William Harper, David Harrah, Kevin Hart, Ali Hasan, William Hasker, John Haugeland, Roger Hausheer, William Heald, Peter Heath, Richard Heck, John F. Heil, Vincent F. Hendricks, Stephen Hetherington, Francis Heylighen, Kathleen Marie Higgins, Risto Hilpinen, Harold T. Hodes, Joshua Hoffman, Alan Holland, Robert L. Holmes, Richard Holton, Brad W. Hooker, Terence E. Horgan, Tamara Horowitz, Paul Horwich, Vittorio Hösle, Paul Hoβfeld, Daniel Howard-Snyder, Frances Howard-Snyder, Anne Hudson, Deal W. Hudson, Carl A. Huffman, David L. Hull, Patricia Huntington, Thomas Hurka, Paul Hurley, Rosalind Hursthouse, Guillermo Hurtado, Ronald E. Hustwit, Sarah Hutton, Jonathan Jenkins Ichikawa, Harry A. Ide, David Ingram, Philip J. Ivanhoe, Alfred L. Ivry, Frank Jackson, Dale Jacquette, Joseph Jedwab, Richard Jeffrey, David Alan Johnson, Edward Johnson, Mark D. Jordan, Richard Joyce, Hwa Yol Jung, Robert Hillary Kane, Tomis Kapitan, Jacquelyn Ann K. Kegley, James A. Keller, Ralph Kennedy, Sergei Khoruzhii, Jaegwon Kim, Yersu Kim, Nathan L. King, Patricia Kitcher, Peter D. Klein, E. D. Klemke, Virginia Klenk, George L. Kline, Christian Klotz, Simo Knuuttila, Joseph J. Kockelmans, Konstantin Kolenda, Sebastian Tomasz Kołodziejczyk, Isaac Kramnick, Richard Kraut, Fred Kroon, Manfred Kuehn, Steven T. Kuhn, Henry E. Kyburg, John Lachs, Jennifer Lackey, Stephen E. Lahey, Andrea Lavazza, Thomas H. Leahey, Joo Heung Lee, Keith Lehrer, Dorothy Leland, Noah M. Lemos, Ernest LePore, Sarah-Jane Leslie, Isaac Levi, Andrew Levine, Alan E. Lewis, Daniel E. Little, Shu-hsien Liu, Shu-hsien Liu, Alan K. L. Chan, Brian Loar, Lawrence B. Lombard, John Longeway, Dominic McIver Lopes, Michael J. Loux, E. J. Lowe, Steven Luper, Eugene C. Luschei, William G. Lycan, David Lyons, David Macarthur, Danielle Macbeth, Scott MacDonald, Jacob L. Mackey, Louis H. Mackey, Penelope Mackie, Edward H. Madden, Penelope Maddy, G. B. Madison, Bernd Magnus, Pekka Mäkelä, Rudolf A. Makkreel, David Manley, William E. Mann (W.E.M.), Vladimir Marchenkov, Peter Markie, Jean-Pierre Marquis, Ausonio Marras, Mike W. Martin, A. P. Martinich, William L. McBride, David McCabe, Storrs McCall, Hugh J. McCann, Robert N. McCauley, John J. McDermott, Sarah McGrath, Ralph McInerny, Daniel J. McKaughan, Thomas McKay, Michael McKinsey, Brian P. McLaughlin, Ernan McMullin, Anthonie Meijers, Jack W. Meiland, William Jason Melanson, Alfred R. Mele, Joseph R. Mendola, Christopher Menzel, Michael J. Meyer, Christian B. Miller, David W. Miller, Peter Millican, Robert N. Minor, Phillip Mitsis, James A. Montmarquet, Michael S. Moore, Tim Moore, Benjamin Morison, Donald R. Morrison, Stephen J. Morse, Paul K. Moser, Alexander P. D. Mourelatos, Ian Mueller, James Bernard Murphy, Mark C. Murphy, Steven Nadler, Jan Narveson, Alan Nelson, Jerome Neu, Samuel Newlands, Kai Nielsen, Ilkka Niiniluoto, Carlos G. Noreña, Calvin G. Normore, David Fate Norton, Nikolaj Nottelmann, Donald Nute, David S. Oderberg, Steve Odin, Michael O’Rourke, Willard G. Oxtoby, Heinz Paetzold, George S. Pappas, Anthony J. Parel, Lydia Patton, R. P. Peerenboom, Francis Jeffry Pelletier, Adriaan T. Peperzak, Derk Pereboom, Jaroslav Peregrin, Glen Pettigrove, Philip Pettit, Edmund L. Pincoffs, Andrew Pinsent, Robert B. Pippin, Alvin Plantinga, Louis P. Pojman, Richard H. Popkin, John F. Post, Carl J. Posy, William J. Prior, Richard Purtill, Michael Quante, Philip L. Quinn, Philip L. Quinn, Elizabeth S. Radcliffe, Diana Raffman, Gerard Raulet, Stephen L. Read, Andrews Reath, Andrew Reisner, Nicholas Rescher, Henry S. Richardson, Robert C. Richardson, Thomas Ricketts, Wayne D. Riggs, Mark Roberts, Robert C. Roberts, Luke Robinson, Alexander Rosenberg, Gary Rosenkranz, Bernice Glatzer Rosenthal, Adina L. Roskies, William L. Rowe, T. M. Rudavsky, Michael Ruse, Bruce Russell, Lilly-Marlene Russow, Dan Ryder, R. M. Sainsbury, Joseph Salerno, Nathan Salmon, Wesley C. Salmon, Constantine Sandis, David H. Sanford, Marco Santambrogio, David Sapire, Ruth A. Saunders, Geoffrey Sayre-McCord, Charles Sayward, James P. Scanlan, Richard Schacht, Tamar Schapiro, Frederick F. Schmitt, Jerome B. Schneewind, Calvin O. Schrag, Alan D. Schrift, George F. Schumm, Jean-Loup Seban, David N. Sedley, Kenneth Seeskin, Krister Segerberg, Charlene Haddock Seigfried, Dennis M. Senchuk, James F. Sennett, William Lad Sessions, Stewart Shapiro, Tommie Shelby, Donald W. Sherburne, Christopher Shields, Roger A. Shiner, Sydney Shoemaker, Robert K. Shope, Kwong-loi Shun, Wilfried Sieg, A. John Simmons, Robert L. Simon, Marcus G. Singer, Georgette Sinkler, Walter Sinnott-Armstrong, Matti T. Sintonen, Lawrence Sklar, Brian Skyrms, Robert C. Sleigh, Michael Anthony Slote, Hans Sluga, Barry Smith, Michael Smith, Robin Smith, Robert Sokolowski, Robert C. Solomon, Marta Soniewicka, Philip Soper, Ernest Sosa, Nicholas Southwood, Paul Vincent Spade, T. L. S. Sprigge, Eric O. Springsted, George J. Stack, Rebecca Stangl, Jason Stanley, Florian Steinberger, Sören Stenlund, Christopher Stephens, James P. Sterba, Josef Stern, Matthias Steup, M. A. Stewart, Leopold Stubenberg, Edith Dudley Sulla, Frederick Suppe, Jere Paul Surber, David George Sussman, Sigrún Svavarsdóttir, Zeno G. Swijtink, Richard Swinburne, Charles C. Taliaferro, Robert B. Talisse, John Tasioulas, Paul Teller, Larry S. Temkin, Mark Textor, H. S. Thayer, Peter Thielke, Alan Thomas, Amie L. Thomasson, Katherine Thomson-Jones, Joshua C. Thurow, Vzalerie Tiberius, Terrence N. Tice, Paul Tidman, Mark C. Timmons, William Tolhurst, James E. Tomberlin, Rosemarie Tong, Lawrence Torcello, Kelly Trogdon, J. D. Trout, Robert E. Tully, Raimo Tuomela, John Turri, Martin M. Tweedale, Thomas Uebel, Jennifer Uleman, James Van Cleve, Harry van der Linden, Peter van Inwagen, Bryan W. Van Norden, René van Woudenberg, Donald Phillip Verene, Samantha Vice, Thomas Vinci, Donald Wayne Viney, Barbara Von Eckardt, Peter B. M. Vranas, Steven J. Wagner, William J. Wainwright, Paul E. Walker, Robert E. Wall, Craig Walton, Douglas Walton, Eric Watkins, Richard A. Watson, Michael V. Wedin, Rudolph H. Weingartner, Paul Weirich, Paul J. Weithman, Carl Wellman, Howard Wettstein, Samuel C. Wheeler, Stephen A. White, Jennifer Whiting, Edward R. Wierenga, Michael Williams, Fred Wilson, W. Kent Wilson, Kenneth P. Winkler, John F. Wippel, Jan Woleński, Allan B. Wolter, Nicholas P. Wolterstorff, Rega Wood, W. Jay Wood, Paul Woodruff, Alison Wylie, Gideon Yaffe, Takashi Yagisawa, Yutaka Yamamoto, Keith E. Yandell, Xiaomei Yang, Dean Zimmerman, Günter Zoller, Catherine Zuckert, Michael Zuckert, Jack A. Zupko (J.A.Z.)
- Edited by Robert Audi, University of Notre Dame, Indiana
-
- Book:
- The Cambridge Dictionary of Philosophy
- Published online:
- 05 August 2015
- Print publication:
- 27 April 2015, pp ix-xxx
-
- Chapter
- Export citation
Contributors
-
- By Peter J. D. Andrews, Sandeep Ankolekar, Issam A. Awad, Omar Ayoub, Philip Bath, Jürgen Bardutzky, Alexander Beck, Patrícia Canhão, J. Ricardo Carhuapoma, Winward Choy, Mahua Dey, Rajat Dhar, Michael C. Diringer, Arnd Dörfler, Joshua R. Dusick, Justin A. Dye, Corina Epple, José M. Ferro, Reiner Fietkau, Anthony Frattalone, Philippe Gailloud, Oliver Ganslandt, Anil Gholkar, Philipp Gölitz, Barbara A. Gregson, Daniel Hanley, Thomas M. Hemmen, Dan Holmes, Hagen B. Huttner, Jennifer Jaffe, Olav Jansen, Eric Jüttler, Karl L. Kiening, Martin Köhrmann, Rainer Kollmar, Kara L. Krajewski, Joji B. Kuramatsu, Perttu J. Lindsberg, Andrew Losiniecki, Patrick Lyden, Neil A. Martin, Heinrich P. Mattle, A. David Mendelow, Patrick Mitchell, Daniel T. Nagasawa, Neeraj S. Naval, Jan-Oliver Neumann, Tim Nowe, Berk Orakcioglu, Soenke Peters, Sara Pitoni, François Proust, Adnan I. Qureshi, Martin Radvany, Elise Rowan, Tiina Sairanen, Oliver W. Sakowitz, Edgar Santos, Peter D. Schellinger, Stefan Schwab, Günter Seidel, Sabine Semrau, Louise Sinclair, Dimitre Staykov, Thorsten Steiner, Jeanne Teitelbaum, Wondwossen G. Tekle, Andreas W. Unterberg, Katayoun Vahedi, H. Bart van der Worp, Paul M. Vespa, Raghu Vindlacheruvu, Jens Witsch, Isaac Yang, Wendy C. Ziai, Mario Zuccarello, Klaus Zweckberger
- Edited by Stefan Schwab, Daniel Hanley, A. David Mendelow
-
- Book:
- Critical Care of the Stroke Patient
- Published online:
- 05 June 2014
- Print publication:
- 05 June 2014, pp viii-xii
-
- Chapter
- Export citation
Plasma alkylresorcinol concentrations, biomarkers of whole-grain wheat and rye intake, in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
- Cecilie Kyrø, Anja Olsen, H. B(as). Bueno-de-Mesquita, Guri Skeie, Steffen Loft, Per Åman, Max Leenders, Vincent K. Dik, Peter D. Siersema, Tobias Pischon, Jane Christensen, Kim Overvad, Marie-Christine Boutron-Ruault, Guy Fagherazzi, Vanessa Cottet, Tilman Kühn, Jenny Chang-Claude, Heiner Boeing, Antonia Trichopoulou, Androniki Naska, Despoina Oikonomidou, Giovanna Masala, Valeria Pala, Rosario Tumino, Paolo Vineis, Amalia Mattiello, Petra H. Peeters, Toril Bakken, Elisabete Weiderpass, Lene Angell Åsli, Soledad Sánchez, Paula Jakszyn, María-José Sánchez, Pilar Amiano, José María Huerta, Aurelio Barricarte, Ingrid Ljuslinder, Richard Palmqvist, Kay-Tee Khaw, Nick Wareham, Timothy J. Key, Ruth C. Travis, Nadia Slimani, Heinz Freisling, Pietro Ferrari, Marc J. Gunter, Neil Murphy, Elio Riboli, Anne Tjønneland, Rikard Landberg
-
- Journal:
- British Journal of Nutrition / Volume 111 / Issue 10 / 28 May 2014
- Published online by Cambridge University Press:
- 13 February 2014, pp. 1881-1890
- Print publication:
- 28 May 2014
-
- Article
-
- You have access Access
- HTML
- Export citation
-
Whole-grain intake has been reported to be associated with a lower risk of several lifestyle-related diseases such as type 2 diabetes, CVD and some types of cancers. As measurement errors in self-reported whole-grain intake assessments can be substantial, dietary biomarkers are relevant to be used as complementary tools for dietary intake assessment. Alkylresorcinols (AR) are phenolic lipids found almost exclusively in whole-grain wheat and rye products among the commonly consumed foods and are considered as valid biomarkers of the intake of these products. In the present study, we analysed the plasma concentrations of five AR homologues in 2845 participants from ten European countries from a nested case–control study in the European Prospective Investigation into Cancer and Nutrition. High concentrations of plasma total AR were found in participants from Scandinavia and Central Europe and lower concentrations in those from the Mediterranean countries. The geometric mean plasma total AR concentrations were between 35 and 41 nmol/l in samples drawn from fasting participants in the Central European and Scandinavian countries and below 23 nmol/l in those of participants from the Mediterranean countries. The whole-grain source (wheat or rye) could be determined using the ratio of two of the homologues. The main source was wheat in Greece, Italy, the Netherlands and the UK, whereas rye was also consumed in considerable amounts in Germany, Denmark and Sweden. The present study demonstrates a considerable variation in the plasma concentrations of total AR and concentrations of AR homologues across ten European countries, reflecting both quantitative and qualitative differences in the intake of whole-grain wheat and rye.
List of contributors
-
- By Dale C. Allison, John Barton, Pierre-Maurice Bogaert, Jonathan G. Campbell, James Carleton Paget, J. F. Coakley, John J. Collins, Kristin De Troyer, Gilles Dorival, Mark Edwards, J. K. Elliott, Mark W. Elliott, Wolf-Peter Funk, Thomas Graumann, Lucy Grig, Carol Harrison, C. T. R. Hayward, Michael J. Hollerich, William Horbury, Larry W. Hurtado, Jan Joosten, Adam Kamesar, Chris Keith, Geoffrey Khan, Wolfram Kinzig, Winrich Löhr, David C. Parker, Gerard Rouwhorst, Joachim Schaper, William M. Schniedewind, Günter Stemberger, Emanuel Tov, Eugene Ulrich, Joseph Verheyden, James W. Watts, Peter J. Williams, Frances M. Young
- Edited by James Carleton Paget, University of Cambridge, Joachim Schaper, University of Aberdeen
-
- Book:
- The New Cambridge History of the Bible
- Published online:
- 05 May 2013
- Print publication:
- 09 May 2013, pp x-xi
-
- Chapter
- Export citation
Contributors
-
- By Ghazi Al-Rawas, Vazken Andréassian, Tianqi Ao, Stacey A. Archfield, Berit Arheimer, András Bárdossy, Trent Biggs, Günter Blöschl, Theresa Blume, Marco Borga, Helge Bormann, Gianluca Botter, Tom Brown, Donald H. Burn, Sean K. Carey, Attilio Castellarin, Francis Chiew, François Colin, Paulin Coulibaly, Armand Crabit, Barry Croke, Siegfried Demuth, Qingyun Duan, Giuliano Di Baldassarre, Thomas Dunne, Ying Fan, Xing Fang, Boris Gartsman, Alexander Gelfan, Mikhail Georgievski, Nick van de Giesen, David C. Goodrich, Hoshin V. Gupta, Khaled Haddad, David M. Hannah, H. A. P. Hapuarachchi, Hege Hisdal, Kamila Hlavčová, Markus Hrachowitz, Denis A. Hughes, Günter Humer, Ruud Hurkmans, Vito Iacobellis, Elena Ilyichyova, Hiroshi Ishidaira, Graham Jewitt, Shaofeng Jia, Jeffrey R. Kennedy, Anthony S. Kiem, Robert Kirnbauer, Thomas R. Kjeldsen, Jürgen Komma, Leonid M. Korytny, Charles N. Kroll, George Kuczera, Gregor Laaha, Henny A. J. van Lanen, Hjalmar Laudon, Jens Liebe, Shijun Lin, Göran Lindström, Suxia Liu, Jun Magome, Danny G. Marks, Dominic Mazvimavi, Jeffrey J. McDonnell, Brian L. McGlynn, Kevin J. McGuire, Neil McIntyre, Thomas A. McMahon, Ralf Merz, Robert A. Metcalfe, Alberto Montanari, David Morris, Roger Moussa, Lakshman Nandagiri, Thomas Nester, Taha B. M. J. Ouarda, Ludovic Oudin, Juraj Parajka, Charles S. Pearson, Murray C. Peel, Charles Perrin, John W. Pomeroy, David A. Post, Ataur Rahman, Liliang Ren, Magdalena Rogger, Dan Rosbjerg, José Luis Salinas, Jos Samuel, Eric Sauquet, Hubert H. G. Savenije, Takahiro Sayama, John C. Schaake, Kevin Shook, Murugesu Sivapalan, Jon Olav Skøien, Chris Soulsby, Christopher Spence, R. ‘Sri’ Srikanthan, Tammo S. Steenhuis, Jan Szolgay, Yasuto Tachikawa, Kuniyoshi Takeuchi, Lena M. Tallaksen, Dörthe Tetzlaff, Sally E. Thompson, Elena Toth, Peter A. Troch, Remko Uijlenhoet, Carl L. Unkrich, Alberto Viglione, Neil R. Viney, Richard M. Vogel, Thorsten Wagener, M. Todd Walter, Guoqiang Wang, Markus Weiler, Rolf Weingartner, Erwin Weinmann, Hessel Winsemius, Ross A. Woods, Dawen Yang, Chihiro Yoshimura, Andy Young, Gordon Young, Erwin Zehe, Yongqiang Zhang, Maichun C. Zhou
- Edited by Günter Blöschl, Technische Universität Wien, Austria, Murugesu Sivapalan, University of Illinois, Urbana-Champaign, Thorsten Wagener, University of Bristol, Alberto Viglione, Technische Universität Wien, Austria, Hubert Savenije, Technische Universiteit Delft, The Netherlands
-
- Book:
- Runoff Prediction in Ungauged Basins
- Published online:
- 05 April 2013
- Print publication:
- 18 April 2013, pp ix-xiv
-
- Chapter
- Export citation
Contributors
-
- By Lee R. Berger, Fred L. Bookstein, Günter Bräuer, Michel Brunet, Steven E. Churchill, Ronald J. Clarke, M. Christopher Dean, Michelle S. M. Drapeau, Sarah Elton, Dean Falk, Andrew Gallagher, John A. J. Gowlett, Colin Groves, Philipp Gunz, Adam Hartstone-Rose, Jason Hemingway, Ralph L. Holloway, Vance T. Hutchinson, William L. Jungers, Ivor Janković, Kevin L. Kuykendall, Sang-Hee Lee, Julia Lee-Thorp, Paul R. Manger, Emma Mbua, Henry M. McHenry, Philipp Mitteroecker, Simon Neubauer, Osbjorn M. Pearson, Travis R. Pickering, Martin Pickford, Sally C. Reynolds, Brian G. Richmond, Avraham Ronen, Darryl J. de Ruiter, Brigitte Senut, Fred H. Smith, Muhammad A. Spocter, Matt Sponheimer, J. Francis Thackeray, Phillip V. Tobias, Peter S. Ungar, Lyn Wadley, Gerhard W. Weber, Milford H. Wolpoff, B. Headman Zondo
- Edited by Sally C. Reynolds, University of the Witwatersrand, Johannesburg, Andrew Gallagher, University of Johannesburg
-
- Book:
- African Genesis
- Published online:
- 05 April 2012
- Print publication:
- 29 March 2012, pp viii-xii
-
- Chapter
- Export citation
Association between dietary phyto-oestrogens and bone density in men and postmenopausal women
- Gunter G. C. Kuhnle, Heather A. Ward, Anna Vogiatzoglou, Robert N. Luben, Angela Mulligan, Nicholas J. Wareham, Nita G. Forouhi, Kay-Tee Khaw
-
- Journal:
- British Journal of Nutrition / Volume 106 / Issue 7 / 14 October 2011
- Published online by Cambridge University Press:
- 17 May 2011, pp. 1063-1069
- Print publication:
- 14 October 2011
-
- Article
-
- You have access Access
- HTML
- Export citation
-
Phyto-oestrogens have been associated with a decreased risk for osteoporosis, but results from intervention and observational studies in Western countries have been inconsistent. In the present study, we investigated the association between habitual phyto-oestrogen intake and broadband ultrasound attenuation (BUA) of the calcanaeum as a marker of bone density. We collected 7 d records of diet, medical history and demographic and anthropometric data from participants (aged 45–75 years) in the European Prospective Investigation into Cancer-Norfolk study. Phyto-oestrogen (biochanin A, daidzein, formononetin; genistein, glycitein; matairesinol; secoisolariciresinol; enterolactone; equol) intake was determined using a newly developed food composition database. Bone density was assessed using BUA of the calcanaeum. Associations between bone density and phyto-oestrogen intake were investigated in 2580 postmenopausal women who were not on hormone replacement therapy and 4973 men. Median intake of total phyto-oestrogens was 876 (interquartile range 412) μg/d in postmenopausal women and 1212 (interquartile range 604) μg/d in men. The non-soya isoflavones formononetin and biochanin A were marginally significant or significantly associated with BUA in postmenopausal women (β = 1·2; P < 0·1) and men (β = 1·2; P < 0·05), respectively; enterolignans and equol were positively associated with bone density in postmenopausal women, but this association became non-significant when dietary Ca was added to the model. In the lowest quintile of Ca intake, soya isoflavones were positively associated with bone density in postmenopausal women (β = 1·4; P < 0·1). The present results therefore suggest that non-soya isoflavones are associated with bone density independent of Ca, whereas the association with soya or soya isoflavones is affected by dietary Ca.